Princess Diana captured on CCTV as she left the Ritz Hotel in Paris shortly before her death in a car crash in 1997.[Reuters] The UK government has finally released a heavily redacted official log detailing the events following the death of Princess Diana in 1997.
SAN DIEGO, April 11, 2017 /PRNewswire/-- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that the U.S. Food and Drug Administration (FDA) has approved INGREZZAâ¢ (valbenazine) capsules for the treatment of adults with tardive dyskinesia (TD).
Afrezza, a rapid-acting inhaled insulin, is now FDA-approved for use before meals for both type 1 and type 2 diabetes. The drug peaks in your blood in about 15-20 minutes, researchers say, and it clears your body in 2-3 hours. It must be used along with long-acting insulin in people with type 1 diabetes.